Graves' disease ophtalmopathy medical therapy

	Graves' disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Differentiating Graves' disease from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Approach
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy Hyperthyroidism Ophtalmopathy Dermopathy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Graves' disease ophtalmopathy medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Graves' disease ophtalmopathy medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Graves' disease ophtalmopathy medical therapy
CDC on Graves' disease ophtalmopathy medical therapy
Graves' disease ophtalmopathy medical therapy in the news
Blogs on Graves' disease ophtalmopathy medical therapy
Directions to Hospitals Treating Graves' disease
Risk calculators and risk factors for Graves' disease ophtalmopathy medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2]

Overview

Treatment for ophthalmopathy depends on the phase and severity of the disease.
It is ranged from enhancement of tear-film quality and maintenance of ocular surface moisture for mild disease to intravenously administered pulse glucocorticoid therapy for severe and sight threatening disease.

The table below summarizes the treatment options for ophtalmopathy.